Cambridge leads national drug trial to prevent deaths after COVID-19 patients leave hospital
25 March 2021
A UK-wide study is being launched to reduce the number of people who die in the months following a stay in hospital with COVID-19. The clinical trial - named HEAL-COVID - also aims to cut the number of patients being readmitted to hospital with complications as a result of having COVID. Read the original article here>
Cambridge leads trial to see if tapeworm drug can boost protection from COVID-19 among vulnerable
23 March 2021
UK researchers are launching a clinical trial to investigate if the drug niclosamide, usually used to treat tapeworms, can prevent COVID-19 infection in vulnerable, high risk kidney patients and reduce the number of people who become seriously ill or die from it. Read the original article here>
22 March 2021
The story behind the UK's world-leading SARS-CoV-2 genomics capability. For years, Professor Sharon Peacock has been using cutting-edge genome sequencing to track outbreaks of infectious diseases and to better understand how pathogens spread and evolve. When SARS-CoV-2 emerged just over a year ago, she knew that her work...
Follow us on Twitter
Watch our webinars
Sign up to our newsletter
FCEs provide interdisciplinary training programmes for students, fellows and continuing education physicians through FOCIS assisted opportunities
© 2021 University of Cambridge
